| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Consumer health outlet |
| Population | Women |
| Source | Talkspace |
| URL | talkspace.com/blog/low-testosterone-in-women (opens in a new tab) |
Specific Claim Evaluated
There is insufficient evidence to support testosterone therapy for improving mood or cognitive performance in postmenopausal women.
Primary Research Supporting or Contradicting the Claim
The consensus statement finds insufficient evidence for cognitive benefit and no effect on depressed mood (Davis et al., 2019); a 2026 meta-analysis found no significant effects on cognition (Faulkner et al., 2026).
Corrected Evidence-Based Interpretation
Accurate.
Rationale for Grade
The article uses hedged language for possible symptoms and states plainly that evidence does not support testosterone for mood or cognition. It is clinically reviewed. The core claim is consistent with consensus and meta-analytic data.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Faulkner A, Desai R, Keay N, Ellahi SA, Spector A. Testosterone therapy for cognition in menopause: a systematic review and meta-analysis. Reprod Fertil. 2026;7(4). PMID
Supporting excerpt: "insufficient to establish an effect rather than as evidence of no effect"